• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized
as an important cause of cardiovascular morbidity and mortality that affects> 230 million …

Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

Within the context of screening tests, it is important to avoid misconceptions about sensitivity,
specificity, and predictive values. In this article, therefore, foundations are first established …

Peripheral artery disease (PAD) is a prevalent condition that confers substantial morbidity
and mortality and remains underdiagnosed as well as undertreated in the overall …

Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality,
mainly from cardiovascular causes. The association between CKD on hemodialysis and …

Background Lower extremity peripheral artery disease is the third leading cause of
atherosclerotic cardiovascular morbidity, following coronary artery disease and stroke. This …

The ankle-brachial index (ABI) is the ratio of the systolic blood pressure (SBP) measured at
the ankle to that measured at the brachial artery. Originally described by Winsor1 in 1950 …

A comprehensive and systematic assessment of disability and mortality due to lower
extremity peripheral artery disease (PAD) is lacking. Therefore, we estimated PAD deaths …

BACKGROUND: Peripheral arterial disease (PAD) can be diagnosed noninvasively by
segmental blood pressure measurement and calculating an ankle-brachial index (ABI) or …